Skip to main content
Erschienen in:

23.10.2019 | Case Report

Rare Sites Metastasis in Ovarian Carcinoma: a Compilation of 3 Case Reports

verfasst von: Megha Nandwani, Debabrata Barmon, Dimpy Begum, Amal C. Kataki

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Auszug

Ovarian malignancy is a common cancer of the female genital tract. The age adjusted incidence of ovarian cancer in Kamrup Urban district of Assam, India, for 2010–2014 was 9.17 [1]. According to the American National Cancer Registry of 2012, a total of 22,280 cases of cancer of ovary were diagnosed [2]. The mortality rate was also high and even the recurrence rate that was around 65 to 75%. The peritoneal cavity showed the highest rate of recurrence [3]. Metastasis to the skin is not commonly seen with cancers of the internal organs. A very few cases have been reported in the past where ovarian cancers have shown spread to the skin and almost none has been seen to show recurrence or metastasis to the rectus muscle. Hu SC et al. conducted a study at Taiwanese medical center and reported an incidence of 1.02% of cases with internal malignancies to have cutaneous metastasis [4]. Carcinoma breast showed the maximum rates of these metastases and the most common histopathology was adenocarcinoma. …
Literatur
1.
Zurück zum Zitat Barman D, Sharma JD, Barmon D, Kataki AC, Sharma A, Kalita M (2017) Epidemiology of gynaecological cancers in Kamrup Urban District cancer registry. Indian J Cancer 54(1):388–391CrossRef Barman D, Sharma JD, Barmon D, Kataki AC, Sharma A, Kalita M (2017) Epidemiology of gynaecological cancers in Kamrup Urban District cancer registry. Indian J Cancer 54(1):388–391CrossRef
2.
Zurück zum Zitat Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1):10–29CrossRef Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1):10–29CrossRef
3.
Zurück zum Zitat Craig CD, Iglesias DA, Watkins J, Coleman RL, Kilgore L, Ramirez PT (2013) Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin. Gynecol Oncol Case Rep 5:64–66CrossRef Craig CD, Iglesias DA, Watkins J, Coleman RL, Kilgore L, Ramirez PT (2013) Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin. Gynecol Oncol Case Rep 5:64–66CrossRef
4.
Zurück zum Zitat Hu SC, Chen GS, Wu CS, Chai CY, Chen WT, Lan CC (2009 Mar) Rates of cutaneous metastases from different internal malignancies: experience from a Taiwanese medical center. J Am Acad Dermatol 60(3):379–387CrossRef Hu SC, Chen GS, Wu CS, Chai CY, Chen WT, Lan CC (2009 Mar) Rates of cutaneous metastases from different internal malignancies: experience from a Taiwanese medical center. J Am Acad Dermatol 60(3):379–387CrossRef
5.
Zurück zum Zitat Yilmaz Z, Bese T, Demirkiran F (2001) Skin metastasis in ovarian carcinoma. Int J Gynecol Cancer 16(Suppl 1):414–418CrossRef Yilmaz Z, Bese T, Demirkiran F (2001) Skin metastasis in ovarian carcinoma. Int J Gynecol Cancer 16(Suppl 1):414–418CrossRef
6.
Zurück zum Zitat Demirci S, Yavas F, Ozsaran Z, Ozsaran A, Dikmen Y, Zekioglu O, Karabulut B, Aras AB (2010) Palliative radiotherapy for the skin metastasis of ovarian cancer: a case report and review of the literature. Med Oncol 27(3):628–631CrossRef Demirci S, Yavas F, Ozsaran Z, Ozsaran A, Dikmen Y, Zekioglu O, Karabulut B, Aras AB (2010) Palliative radiotherapy for the skin metastasis of ovarian cancer: a case report and review of the literature. Med Oncol 27(3):628–631CrossRef
7.
Zurück zum Zitat Woopen H, Sehouli J (2009) Current and future options in the treatment of malignant ascites in ovarian cancer. Anticancer Res 29:3353–3359PubMed Woopen H, Sehouli J (2009) Current and future options in the treatment of malignant ascites in ovarian cancer. Anticancer Res 29:3353–3359PubMed
8.
Zurück zum Zitat Abbas O, Salem Z, Haddad F, Kibbi AG (2010) Perforating cutaneous metastasis from an ovarian adenocarcinoma. J Cutan Pathol 37:e53–e56CrossRef Abbas O, Salem Z, Haddad F, Kibbi AG (2010) Perforating cutaneous metastasis from an ovarian adenocarcinoma. J Cutan Pathol 37:e53–e56CrossRef
9.
Zurück zum Zitat Antonio AM, Alves JV, Goulao J et al (2016) Ovarian carcinoma presenting as cutaneous nasal metastasis. An Bras Dermatol 91(5 suppl 1):101–104CrossRef Antonio AM, Alves JV, Goulao J et al (2016) Ovarian carcinoma presenting as cutaneous nasal metastasis. An Bras Dermatol 91(5 suppl 1):101–104CrossRef
10.
Zurück zum Zitat Kim MK, Kim SH, Lee YY, Choi CH, Kim TJ, Lee JW et al (2012) Metastatic skin lesions on lower extremities in a patient with recurrent serous papillary ovarian carcinoma: a case report and literature review. Cancer Res Treat 44:142CrossRef Kim MK, Kim SH, Lee YY, Choi CH, Kim TJ, Lee JW et al (2012) Metastatic skin lesions on lower extremities in a patient with recurrent serous papillary ovarian carcinoma: a case report and literature review. Cancer Res Treat 44:142CrossRef
11.
Zurück zum Zitat Gupta N, Bansal U, Mahajan N, Yadav MS (2011) Abdominal wall metastasis in scar after open resection of an adrenocortical carcinoma. Clin Pract 30:e9 Gupta N, Bansal U, Mahajan N, Yadav MS (2011) Abdominal wall metastasis in scar after open resection of an adrenocortical carcinoma. Clin Pract 30:e9
12.
Zurück zum Zitat Stojadinovic A, Hoos A, Karpoff HM, Leung DH, Antonescu CR, Brennan MF, Lewis JJ (2001) Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatment. Arch Surg 136:70–79CrossRef Stojadinovic A, Hoos A, Karpoff HM, Leung DH, Antonescu CR, Brennan MF, Lewis JJ (2001) Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatment. Arch Surg 136:70–79CrossRef
13.
Zurück zum Zitat Qi C, Yu X-L, Liang P, Cheng ZG, Liu FY, Han ZY, Yu J (2012) Ultrasound-guided microwave ablation for abdominal wall metastatic tumors: a preliminary study. World J Gastroenterol: WJG 18(23):3008–3014CrossRef Qi C, Yu X-L, Liang P, Cheng ZG, Liu FY, Han ZY, Yu J (2012) Ultrasound-guided microwave ablation for abdominal wall metastatic tumors: a preliminary study. World J Gastroenterol: WJG 18(23):3008–3014CrossRef
14.
Zurück zum Zitat Ba M-C, Long H, Zhang X-L, Gong YF, Yan ZF, Wang S, Tang YQ, Cui SZ (2017) Port-site metastases and chimney effect of B-ultrasound-guided and laparoscopically-assisted hyperthermic intraperitoneal perfusion chemotherapy. Yonsei Med J 58(3):497–504CrossRef Ba M-C, Long H, Zhang X-L, Gong YF, Yan ZF, Wang S, Tang YQ, Cui SZ (2017) Port-site metastases and chimney effect of B-ultrasound-guided and laparoscopically-assisted hyperthermic intraperitoneal perfusion chemotherapy. Yonsei Med J 58(3):497–504CrossRef
15.
Zurück zum Zitat Ramirez PT, Wolf JK, Levenback C (2003) Laparoscopic port-site metastases: etiology and prevention. Gynecol Oncol 91:179–189CrossRef Ramirez PT, Wolf JK, Levenback C (2003) Laparoscopic port-site metastases: etiology and prevention. Gynecol Oncol 91:179–189CrossRef
16.
Zurück zum Zitat Mundra V (2012) A rare case of rectus abdominis metastasis of lung adenocarcinoma. Am J Case Rep 13:177–179CrossRef Mundra V (2012) A rare case of rectus abdominis metastasis of lung adenocarcinoma. Am J Case Rep 13:177–179CrossRef
Metadaten
Titel
Rare Sites Metastasis in Ovarian Carcinoma: a Compilation of 3 Case Reports
verfasst von
Megha Nandwani
Debabrata Barmon
Dimpy Begum
Amal C. Kataki
Publikationsdatum
23.10.2019
Verlag
Springer India
Erschienen in
Indian Journal of Surgical Oncology / Ausgabe 1/2020
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-019-00988-5

Neu im Fachgebiet Chirurgie

Hochrisiko-Spinaliom am besten mit der Mohs-Chirurgie entfernen

Die Mohs-Chirurgie ist zwar mit mehr Aufwand verbunden als die herkömmliche Exzision; für die Versorgung kutaner Hochrisiko-Plattenepithelkarzinome lohnt sich die zeitintensive Technik aber in jedem Fall. Laut einer aktuellen Studie sinkt im Vergleich das Sterberisiko.

Darmpolyp weg – Peptid-Gel gegen Nachblutungen drauf?

Das Nachblutungsrisiko nach einer endoskopischen Mukosaresektion von flachen kolorektalen und duodenalen Adenomen war in der deutschen PURPLE-Studie mit einem hämostatischen Gel nicht kleiner als ohne Prophylaxe.

Krebs-Op. besser erst nach mehrwöchigem Rauchverzicht?

Aktive Raucher haben nach onkologischen Operationen ein höheres Komplikationsrisiko als Nieraucher, aber auch als Exraucher. Damit der Rauchstopp einen Nutzen hat, darf er aber nicht zu kurz vor der Op. erfolgen, wie eine Metaanalyse nahelegt.

Periprozeduraler Myokardschaden nach NSTEMI prognostisch bedeutsam

Erleiden NSTEMI-Patienten und -Patientinnen infolge einer PCI Myokardschädigungen mit oder ohne Infarkt, erhöht das die Gesamtmortalität und das Risiko für weitere schwere Herzereignisse. Dafür sprechen zumindest Daten aus zwei italienischen Zentren.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.